title: Cost analysis of remifentanil and fentanyl for neurosurgical anesthesia.
authors: Global Health Outcomes, Glaxo Wellcome, Inc., Research Triangle Park, NC 27709-3398, USA.
authors: S
authors: S
authors: Hogue
authors: P R
authors: PR
authors: Reese
authors: O
authors: O
authors: Munshi
authors: T
authors: T
authors: Young
mesh_terms: D000701:Analgesics, Opioid / Q000191:economics*; D018686:Anesthetics, Intravenous / Q000191:economics*; D003399:Craniotomy; D004311:Double-Blind Method; D005283:Fentanyl / Q000191:economics*; D017721:Hospital Costs; D006801:Humans; D009657:North Carolina; D010880:Piperidines / Q000191:economics*; D000077208:Remifentanil; D012189:Retrospective Studies; D015173:Supratentorial Neoplasms / Q000601:surgery*
chemical_list: D000701:Analgesics, Opioid; D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil; D005283:Fentanyl